Mobility stakeholders are having in-person meetings with House and Senate offices on Sept 10 to advocate for improved consumer access to titanium and carbon fiber wheelchairs.

Three things in life are certain—death, taxes, and changes in the healthcare regulatory requirements.

HME grassroots advocacy has been the driving force for advancing 75/25 blended rate provisions through Senate and House committees.

Next year’s edition of the Medtrade show will be February 18-20, 2025 and once again held at the Kay Bailey Hutchison Convention Center in Dallas, Texas.

ResMed recently expanded the size of its board of directors to 11 and has elected Christopher DelOrefice to the board.

On Aug 1, 2024 the Criminal Division of the Department of Justice (DOJ) rolled out a new Corporate Whistleblower Awards Pilot Program.